Department of Infection Prevention and Infectious Diseases, University Hospital of Regensburg, 93053 Regensburg, Germany.
Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, University Hospital of Regensburg, 93053 Regensburg, Germany.
Cells. 2021 Nov 10;10(11):3100. doi: 10.3390/cells10113100.
Signaling via death receptor family members such as TNF-R1 mediates pleiotropic biological outcomes ranging from inflammation and proliferation to cell death. Pro-survival signaling is mediated via TNF-R1 complex I at the cellular plasma membrane. Cell death induction requires complex IIa/b or necrosome formation, which occurs in the cytoplasm. In many cell types, full apoptotic or necroptotic cell death induction requires the internalization of TNF-R1 and receptosome formation to properly relay the signal inside the cell. We interrogated the role of the enzyme A disintegrin and metalloprotease 17 (ADAM17)/TACE (TNF-α converting enzyme) in death receptor signaling in human hematopoietic cells, using pharmacological inhibition and genetic ablation. We show that in U937 and Jurkat cells the absence of ADAM17 does not abrogate, but rather increases TNF mediated cell death. Likewise, cell death triggered via DR3 is enhanced in U937 cells lacking ADAM17. We identified ADAM17 as the key molecule that fine-tunes death receptor signaling. A better understanding of cell fate decisions made via the receptors of the TNF-R1 superfamily may enable us, in the future, to more efficiently treat infectious and inflammatory diseases or cancer.
通过死亡受体家族成员(如 TNF-R1)发出信号,介导了从炎症、增殖到细胞死亡等多种生物学效应。通过 TNF-R1 细胞浆膜上的复合物 I 进行生存信号转导。细胞死亡诱导需要复合物 IIa/b 或坏死体形成,这发生在细胞质中。在许多细胞类型中,完全诱导细胞凋亡或坏死性细胞死亡需要 TNF-R1 的内化和受体复合物的形成,以正确地在细胞内传递信号。我们使用药理学抑制和基因敲除来研究酶 A 分解素金属蛋白酶 17(ADAM17/TACE(TNF-α转化酶))在人造血细胞中死亡受体信号转导中的作用。我们发现在 U937 和 Jurkat 细胞中,缺乏 ADAM17 不会阻断,而是增加 TNF 介导的细胞死亡。同样,在缺乏 ADAM17 的 U937 细胞中,DR3 触发的细胞死亡增强。我们确定 ADAM17 是精细调节死亡受体信号转导的关键分子。更好地了解通过 TNF-R1 超家族受体做出的细胞命运决定,将来可能使我们能够更有效地治疗感染和炎症性疾病或癌症。